Hanna Mäenpää

6.4k total citations · 2 hit papers
54 papers, 4.8k citations indexed

About

Hanna Mäenpää is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hanna Mäenpää has authored 54 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hanna Mäenpää's work include Thyroid Cancer Diagnosis and Treatment (9 papers), Retinal Development and Disorders (7 papers) and Glioma Diagnosis and Treatment (6 papers). Hanna Mäenpää is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (9 papers), Retinal Development and Disorders (7 papers) and Glioma Diagnosis and Treatment (6 papers). Hanna Mäenpää collaborates with scholars based in Finland, United States and Malaysia. Hanna Mäenpää's co-authors include Jussi K. Huttunen, Olli P. Heinonen, Vesa Manninen, Matti Mänttäri, Pekka Koskinen, Amos Pasternack, Esko A. Nikkilä, J Pikkarainen, Matti Romo and M. H. Frick and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Hanna Mäenpää

51 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

1987 2.9k citations M. H. Frick, Olli P. Heinonen et al. profile →
Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

1998 665 citations Olli P. Heinonen, Leopold G. Koss et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanna Mäenpää Finland	22	2.0k	1.7k	945	825	746	54	4.8k
Leiv Ose Norway	43	3.6k 1.8×	1.6k 0.9×	866 0.9×	1.0k 1.2×	910 1.2×	161	5.8k
Tamio Teramoto Japan	38	2.6k 1.3×	1.7k 1.0×	878 0.9×	671 0.8×	1.5k 2.0×	212	5.6k
Rafael Carmena Spain	32	2.1k 1.0×	2.1k 1.2×	697 0.7×	489 0.6×	911 1.2×	154	4.6k
Evangelos Liberopoulos Greece	42	2.3k 1.1×	2.2k 1.2×	937 1.0×	499 0.6×	1.1k 1.5×	292	6.2k
Joseph P. McConnell United States	42	3.0k 1.5×	1.4k 0.8×	1.4k 1.5×	1.0k 1.2×	2.0k 2.7×	109	7.9k
Jane Armitage United Kingdom	31	2.6k 1.3×	1.2k 0.7×	807 0.9×	621 0.8×	1.2k 1.6×	92	5.7k
P. Barton Duell United States	33	2.6k 1.3×	1.0k 0.6×	619 0.7×	505 0.6×	745 1.0×	114	4.7k
Diane L. Tribble United States	34	2.9k 1.4×	2.0k 1.1×	1.3k 1.4×	997 1.2×	1.0k 1.4×	65	7.2k
Dennis L. Sprecher United States	46	2.5k 1.2×	1.9k 1.1×	1.4k 1.5×	559 0.7×	1.9k 2.5×	150	7.6k
Alexandros D. Tselepis Greece	46	3.2k 1.6×	2.1k 1.2×	1.3k 1.4×	983 1.2×	1.5k 2.0×	258	7.3k

Countries citing papers authored by Hanna Mäenpää

Since Specialization

Citations

This map shows the geographic impact of Hanna Mäenpää's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Mäenpää with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Mäenpää more than expected).

Fields of papers citing papers by Hanna Mäenpää

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Mäenpää. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Mäenpää. The network helps show where Hanna Mäenpää may publish in the future.

Co-authorship network of co-authors of Hanna Mäenpää

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Mäenpää. A scholar is included among the top collaborators of Hanna Mäenpää based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Mäenpää. Hanna Mäenpää is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keski–Säntti, Harri, Marjaana Luukkaa, Kaisa Lehtiö, et al.. (2022). Hypopharyngeal carcinoma in Finland from 2005 to 2014: outcome remains poor after major changes in treatment. European Archives of Oto-Rhino-Laryngology. 280(3). 1361–1367. 3 indexed citations

Vaalavirta, Leila, et al.. (2020). Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up. Acta Oncologica. 59(9). 1064–1071. 5 indexed citations

Korja, Miikka, Rahul Raj, Karri Seppä, et al.. (2018). Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland. Neuro-Oncology. 21(3). 370–379. 69 indexed citations

Bäck, Leif, et al.. (2017). Accuracy of preoperative MRI to assess lateral neck metastases in papillary thyroid carcinoma. European Archives of Oto-Rhino-Laryngology. 274(11). 3977–3983. 9 indexed citations

Saarto, Tiina, et al.. (2010). Male breast cancer: A survey at the Helsinki University Central Hospital during 1981–2006. Acta Oncologica. 49(3). 322–327. 27 indexed citations

Mäenpää, Hanna, Jorma Heikkonen, Leila Vaalavirta, Mikko Tenhunen, & Heikki Joensuu. (2008). Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study. PLoS ONE. 3(4). e1885–e1885. 81 indexed citations

Toimela, Tarja, Hanna Mäenpää, Marika Mannerström, & Hanna Tähti. (2004). Development of an in vitro blood–brain barrier model—cytotoxicity of mercury and aluminum. Toxicology and Applied Pharmacology. 195(1). 73–82. 51 indexed citations

Hernberg, Micaela, et al.. (2003). Interferon Alfa-2b Three Times Daily and Thalidomide in the Treatment of Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 21(20). 3770–3776. 45 indexed citations

Mäenpää, Hanna, Pirjo Saransaari, & Hanna Tähti. (2003). Kinetics of Inhibition of Glutamate Uptake by Antioestrogens. Pharmacology & Toxicology. 93(4). 174–179. 8 indexed citations

10.

Mäenpää, Hanna, Marika Mannerström, Tarja Toimela, et al.. (2002). Glutamate Uptake is Inhibited by Tamoxifen and Toremifene in Cultured Retinal Pigment Epithelial Cells. Pharmacology & Toxicology. 91(3). 116–122. 35 indexed citations

11.

Mannerström, Marika, Michaela Zorn‐Kruppa, H. Diehl, et al.. (2002). Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells. Toxicology in Vitro. 16(2). 193–200. 29 indexed citations

12.

Niemelä, Mika, Hanna Mäenpää, Petri Salvén, et al.. (2001). Interferon alpha-2a therapy in 18 hemangioblastomas.. PubMed. 7(3). 510–6. 32 indexed citations

13.

Mannerström, Marika, Hanna Mäenpää, Tarja Toimela, Lotta Salminen, & Hanna Tähti. (2001). The Phagocytosis of Rod Outer Segments is Inhibited by Selected Drugs in Retinal Pigment Epithelial Cell Cultures. Pharmacology & Toxicology. 88(1). 27–33. 33 indexed citations

14.

Tähti, Hanna, Hanna Mäenpää, Lotta Salminen, & Tarja Toimela. (1999). Retinal Pigment Epithelial Cell Cultures as a Tool for Evaluating Retinal Toxicity In Vitro. Alternatives to Laboratory Animals. 27(3). 417–424. 2 indexed citations

15.

Heinonen, Olli P., Leopold G. Koss, Demetrius Albanes, et al.. (1998). Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial. JNCI Journal of the National Cancer Institute. 90(6). 440–446. 665 indexed citations breakdown →

16.

Blomqvist, Carl, Kristina von Boguslawski, Ulf‐Håkan Stenman, et al.. (1997). Long-term Prognostic Impact of Immunohistochemical Estrogen Receptor Determinations Compared with Biochemical Receptor Determination in Primary Breast Cancer. Acta Oncologica. 36(5). 530–532. 3 indexed citations

17.

Mäenpää, Hanna, Carl Blomqvist, Tom Wiklund, Timo Lehtonen, & Inkeri Elomaa. (1996). Results of Treatment in Testicular Nonseminoma. Annals of Medicine. 28(4). 311–314.

18.

Gylling, Helena, et al.. (1995). Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer.. Journal of Clinical Oncology. 13(12). 2900–2905. 88 indexed citations

19.

Mänttäri, Matti, Leena Tenkanen, Hanna Mäenpää, Vesa Manninen, & Jussi K. Huttunen. (1993). High-density lipoprotein cholesterol elevation with gemfibrozil: Effects of baseline level and modifying factors. Clinical Pharmacology & Therapeutics. 54(4). 437–447. 6 indexed citations

20.

Mänttäri, Matti, M. H. Frick, Olli P. Heinonen, et al.. (1987). The Helsinki Heart Study: Basic design and randomization procedure. European Heart Journal. 8(suppl I). 1–29. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact